Can cannabis compounds help tame opioid cravings and chronic pain?

NCT ID NCT06544291

First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 3 times

Summary

This phase 2 study at Yale University is testing whether a combination of THC and CBD can reduce both pain sensitivity and opioid cravings in people who have opioid use disorder and chronic low back pain. The 147 participants are all on methadone therapy and will receive either a single dose of CBD (300mg or 600mg), THC, or a placebo in a controlled setting. Researchers will measure pain responses and craving levels over several hours to see if the cannabinoids offer relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
THC and CBD (cannabinoids)
What this could lead to
If it works, this could point toward a new treatment that helps people with opioid use disorder and chronic pain manage both conditions together.
What could go wrong
This is a small, early-phase trial (147 people) testing short-term effects only. The results may not lead to a lasting treatment, and cannabinoids can cause side effects like dizziness or impaired thinking.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Connecticut Mental Health Center

    RECRUITING

    New Haven, Connecticut, 06519, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.